DSGN
Design Therapeutics Inc
NASDAQ: DSGN · HEALTHCARE · BIOTECHNOLOGY
$13.41
+1.82% today
Updated 2026-05-05
Market cap
$822.56M
P/E ratio
—
P/S ratio
29,402.82x
EPS (TTM)
$-1.19
Dividend yield
—
52W range
$3 – $17
Volume
0.4M
Design Therapeutics Inc (DSGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-31.30%
ROA
-20.90%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $834000.00 | $-2.05M | -0.10% | -228.78% | -245.44% |
| 2020 | $226.00 | $-8.28M | -2,212.39% | -3,785,840.71% | -3,663,716.81% |
| 2021 | $0.00 | $-35.53M | — | — | — |
| 2022 | $0.00 | $-58.62M | — | — | — |
| 2023 | $0.00 | $-66.86M | — | — | — |
| 2024 | $0.00 | $-49.59M | — | — | — |
| 2025 | $0.00 | $-69.79M | — | — | — |